Evan McGlinn for The New York Times
Dr. Robert Langer’s research lab is at the forefront of moving academic discoveries into the marketplace.
HOW do you take particles in a test tube, or components in a tiny chip, and turn them into a $100 million company?
Evan McGlinn for The New York Times
Dr. Ralph Weissleder, above, is a co-founder — with Dr. Robert Langer and others — of T2Biosystems. It makes a miniaturized chip that tests for diseases.
Dr. Robert Langer, 64, knows how. Since the 1980s, his Langer Lab at the Massachusetts Institute of Technology has spun out companies whose products treat